Global Coartem (Artemether/Lumefantrine) Market 2022: Huge B2B Opportunities by 2031

Pune, Maharashtra, India, September 14 2022 (Wiredrelease) Prudour Pvt. Ltd –:Coartem (Artemether Lumefantrine) is a medication used to treat malaria. It is a combination of two drugs, artemether and lumefantrine, which work together to kill the malaria parasites in the blood. Coartem is taken as a four-dose course over three days. The first dose is taken as soon as possible after the start of symptoms, and the other doses are taken at eight-hour intervals.

Novartis Announces Plans to Increase Access to Coartem (Artemether Lumefantrine)

Novartis announced plans today to increase access to Coartem (Artemether Lumefantrine), a life-saving treatment for malaria. The move comes as the company seeks to expand its footprint in the fight against the disease, which continues to claim hundreds of thousands of lives each year. Coartem is already being used by millions of people in Africa and Novartis plans to increase production by 20 percent to meet growing demand. The company also plans to invest $100 million over the next five years in research and development for new antimalarial treatments. This is good news for the hundreds of millions of people who live in areas where malaria is endemic. With increased access to Coartem, more lives can be saved and the disease can be brought one step closer to eradication.

Perfect your plan with our report here | request a sample report @ https://market.us/report/coartem-artemether-lumefantrine-market/request-sample/

Key Take-Away

– Competition mapping

– Role of key players across value chain

– End-user analysis to define market strategy

– Industry trends, opportunities and challenges in the market

– Regional and Country breakdown by macro and microeconomic factors

Key Market Segments
Type

Artemether
Lumefantrine

Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Key Market Players included in the report:

Novartis
Sanofi-Aventis
KPC Pharmaceuticals Inc
Guangxi Xiancaotang Pharmaceutical Co. Ltd
Guilin Pharmaceutical Co. Ltd
Kerui Nanhai Pharmaceutical
Kerui Nanhai Pharmaceutical

Furthermore, the years considered for This study are as follows:

2015-2020:: Historical year

2021:: Base year

2022-2031::Forecast period

To turn massive challenges into meaningful change, Make an Inquiry of the report@ https://market.us/report/coartem-artemether-lumefantrine-market/#inquiry

FREQUENTLY ASKED QUESTIONS

How big is the Coartem (Artemether/Lumefantrine) market?

What is the total market worth of Coartem (Artemether/Lumefantrine) market?

What is the Coartem (Artemether/Lumefantrine) market growth?

What are the recent trends affecting the Coartem (Artemether/Lumefantrine) market?

Which segment accounted for the largest Coartem (Artemether/Lumefantrine) market share?

Who are the key companies/players in the Coartem (Artemether/Lumefantrine) market?

What are the factors driving the Coartem (Artemether/Lumefantrine) market?

Which region is expected to project the highest market share in the global Coartem (Artemether/Lumefantrine) market?

Browse Full Report with Facts and Figures of Coartem (Artemether/Lumefantrine) Market Report@ https://market.us/report/coartem-artemether-lumefantrine-market/

The content of this report includes 15+ chapters:

1. Coartem (Artemether/Lumefantrine) Market Product Overview

2. Research Methodology verified by Market.us

3. Impact of COVID-19 on Global Coartem (Artemether/Lumefantrine) Market

4. Voice of Customer

5. Executive Summary

6. Global Coartem (Artemether/Lumefantrine) Market Outlook

7. Asia-Pacific Coartem (Artemether/Lumefantrine) Market Outlook

8. Europe Coartem (Artemether/Lumefantrine) Market Outlook

9. North America Coartem (Artemether/Lumefantrine) Market Outlook

10. South America Coartem (Artemether/Lumefantrine) Market Outlook

11. the Middle East and Africa Coartem (Artemether/Lumefantrine) Market Outlook

12. Market Dynamics

13. Market Trends and Developments

14. Pricing Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. Companies Mentioned